Literature DB >> 9822062

Prevention of venous thromboembolism.

G P Clagett1, F A Anderson, W Geerts, J A Heit, M Knudson, J R Lieberman, G J Merli, H B Wheeler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9822062     DOI： 10.1378/chest.114.5_supplement.531s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  56 in total

Review 1.  Preventing thromboembolic complications in older orthopaedic surgery patients: interventions and outcomes.

Authors:  J W Eikelboom; J S Ginsberg
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 3.923

2.  Thromboprophylaxis after replacement arthroplasty.

Authors:  D P Thomas
Journal:  BMJ       Date:  2001-03-24

Review 3.  A guide to venous thromboembolism risk factor assessment.

Authors:  G D Motykie; L P Zebala; J A Caprini; C E Lee; J I Arcelus; J J Reyna; E B Cohen
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

4.  Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial.

Authors:  R S McLeod; W H Geerts; K W Sniderman; C Greenwood; R C Gregoire; B M Taylor; R E Silverman; K G Atkinson; M Burnstein; J C Marshall; C J Burul; D R Anderson; T Ross; S R Wilson; P Barton
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

5.  Prevention of venous thromboembolism in Wales: results of a survey among general surgeons.

Authors:  E V Williams; R S Williams; J L Hughes; K L Williams; M E Foster; M H Lewis
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

6.  Applying scientific criteria to therapeutic interchange: a balanced analysis of low-molecular-weight heparins.

Authors:  G J Merli; G J Vanscoy; T L Rihn; J B Groce; W McCormick
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

7.  Foot pump prophylaxis for deep venous thrombosis-rate of effective usage following knee and hip arthroplasty.

Authors:  C Charalambous; S Cleanthous; M Tryfonidis; A Goel; R Swindell; D Ellis
Journal:  Int Orthop       Date:  2003-04-25       Impact factor: 3.075

8.  [Profile of patients under treatment with heparin of low molecular weight].

Authors:  M Garrote García; M J Iglesias Piñeiro; A López Gil; R Martín Alvarez
Journal:  Aten Primaria       Date:  2002-09-15       Impact factor: 1.137

9.  Retrieval of Recovery IVC Filter After 1,463-Day Implantation.

Authors:  Michael S Stecker; Alisa Suzuki; Jonathan D Gates
Journal:  Eur J Trauma Emerg Surg       Date:  2009-03-16       Impact factor: 3.693

10.  Alterations in homeostasis after open surgery. A prospective randomized study.

Authors:  T Dedej; E Lamaj; N Marku; V Ostreni; S Bilali
Journal:  G Chir       Date:  2013 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.